Genotoxicity testing of antiparasitic nitrofurans in the Drosophila wing somatic mutation and recombination test
- 1 March 1989
- journal article
- research article
- Published by Oxford University Press (OUP) in Mutagenesis
- Vol. 4 (2) , 105-110
- https://doi.org/10.1093/mutage/4.2.105
Abstract
Nifurtimox and eight structurally related 5-nitrofuran compounds active against Trypanosoma cruzi were tested for genotoxicity in the wing somatic mutation and recombination test in Drosophila melanogaster. Nifurtimox, compound ada and compound 1B were clearly mutagenic and recombinogenic whereas the remaining six compounds were negative. In contrast to the situation in bacterial mutagenicity tests, nitroreductase activity is probably not decisive for the genotoxicity of these compounds in Drosophila. The three non-genotoxic nitrofurans with high antiparasitic activity are promising candidates for the replacement of nifurtimox. However, these compounds require further genotoxicity testing in eukaryotic assay systems for a final evaluation.This publication has 4 references indexed in Scilit:
- Activation of anti-Trypanosoma cruzi drugs to genotoxic metabolites promoted by mammalian microsomal enzymesMutation Research/Genetic Toxicology, 1988
- Micronucleus formation in bone marrow of mice treated with nifurtimox or benznidazoleToxicology Letters, 1985
- Mutagenicity of nifurtimox in Escherichia coliMutation Research/Genetic Toxicology, 1980
- Generation of superoxide anion and hydrogen peroxide induced by nifurtimox in Trypanosoma cruziArchives of Biochemistry and Biophysics, 1979